These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

885 related articles for article (PubMed ID: 25441934)

  • 1. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
    Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
    Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing harms from treatment. Sixteen years of surgery of the axilla for screen-detected breast cancers in Italy.
    Lazzaretti MG; Ponti A; Mano MP; Barca A; Casella D; Frigerio A; Giordano L; Mantellini P; Paduos A; Pitarella S; Ravaioli A; Taffurelli M; Tomatis M; Segnan N
    Breast; 2018 Dec; 42():15-22. PubMed ID: 30138762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
    Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
    Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superparamagnetic iron oxide (SPIO) for axillary mapping in patients with ductal carcinoma in situ undergoing mastectomy: single-institution experience.
    Addae JK; Sweeting RS; Meszoely IM; McCaffrey RL; Kauffmann RM; Kelley MC; Grau AM; Hewitt K
    Breast Cancer Res Treat; 2024 Feb; 204(1):117-121. PubMed ID: 38087058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?
    Ramzi S; Najeeb E; Coulthard J; Jenkins S
    Breast Cancer Res Treat; 2020 Jul; 182(1):47-54. PubMed ID: 32430678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisit the practice of lymph node biopsy in patients diagnosed as ductal carcinoma in situ before operation: a retrospective analysis of 682 cases and evaluation of the role of breast MRI.
    Lai HW; Chang YL; Chen ST; Chang YJ; Wu WP; Chen DR; Kuo SJ; Liao CY; Wu HK
    World J Surg Oncol; 2021 Sep; 19(1):263. PubMed ID: 34470633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Axillary Assessment of Ductal Carcinoma In Situ of the Breast Necessary in All Cases?
    Bellver G; Buch E; Ripoll F; Adrianzen M; Bermejo B; Burgues O; Julve A; Ortega J
    J Surg Res; 2022 Mar; 271():145-153. PubMed ID: 34902737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel node biopsy in ductal carcinoma in situ of the breast: Never justified?
    Sorrentino L; Sartani A; Bossi D; Amadori R; Nebuloni M; Truffi M; Bonzini M; Riggio E; Foschi D; Corsi F
    Breast J; 2018 May; 24(3):325-333. PubMed ID: 29024241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma.
    Topps A; Clay V; Absar M; Howe M; Lim Y; Johnson R; Bundred N
    Eur J Surg Oncol; 2014 Jul; 40(7):813-7. PubMed ID: 24797703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can additional histopathological examination of ultrasound-guided axillary lymph node core biopsies improve preoperative diagnosis of primary breast cancer nodal metastasis?
    Mullen R; Purdie CA; Jordan LB; McLean D; Whelehan P; Vinnicombe S; Brown DC; Evans A
    Clin Radiol; 2013 Jul; 68(7):704-7. PubMed ID: 23518495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
    Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
    Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost/accuracy ratio analysis in breast cancer patients undergoing ultrasound-guided fine-needle aspiration cytology, sentinel node biopsy, and frozen section of node.
    Genta F; Zanon E; Camanni M; Deltetto F; Drogo M; Gallo R; Gilardi C
    World J Surg; 2007 Jun; 31(6):1155-63. PubMed ID: 17464539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
    Han JS; Molberg KH; Sarode V
    Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study.
    Tunon-de-Lara C; Chauvet MP; Baranzelli MC; Baron M; Piquenot J; Le-Bouédec G; Penault-Llorca F; Garbay JR; Blanchot J; Mollard J; Maisongrosse V; Mathoulin-Pélissier S; MacGrogan G
    Ann Surg Oncol; 2015 Nov; 22(12):3853-60. PubMed ID: 25777085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
    Shin YD; Lee HM; Choi YJ
    BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal Surgery for Patients ≥ 70 Undergoing Mastectomy for DCIS? Choose Wisely.
    Dalton EC; Chang C; Cardarelli C; Bleicher RJ; Aggon AA; Porpiglia AS; Pronovost MT; Williams AD
    Ann Surg Oncol; 2024 Oct; 31(11):7498-7507. PubMed ID: 38976159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Surgical Trends for Axillary Lymph Node Management in Patients with Ductal Carcinoma In Situ Using the NSQIP Database: Are We Following National Guidelines?
    Pyfer BJ; Jonczyk M; Jean J; Graham RA; Chen L; Chatterjee A
    Ann Surg Oncol; 2020 Sep; 27(9):3448-3455. PubMed ID: 32232706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.